Despite preexisting cytomegalovirus (CMV) immunity, CMV‐seropositive liver
transplantation (LT) patients remain at risk of CMV infection. We hypothesized that the pre …

Cytomegalovirus (CMV) infection causes significant morbidity and mortality among
transplant recipients. Although it is still not clear if a preemptive strategy is superior to a …

Cytomegalovirus (CMV) infections contracted after liver transplantation put patients at an
increased risk of morbidity and mortality. We analyzed the effects of CMV infection by time of …

Background Cytomegalovirus (CMV) is one of the most common post‐transplant viral
infections causing significant morbidity and occasional mortality. Limited literature on the …

Background. This study determines whether the recipient and donor characteristics that
influence the cytomegalovirus (CMV) infection rate after liver transplantation have changed …

BACKGROUND: Cytomegalovirus (CMV) infection and related disease is a feared
complication after liver transplantation. Antiviral prophylaxis is recommended in clinical …

A vast majority of the transplant recipients are cytomegalovirus (CMV)‐seropositive (R+). We
sought to assess variables predictive of CMV infection, specifically in R+ liver transplant …

Purpose To evaluate epidemiology, risk‐factors, and outcomes of high‐level (HL)
cytomegalovirus (CMV) viremia in liver transplant recipients. Methods Adult patients …

Introduction Although antiviral prophylaxis is effective in preventing early cytomegalovirus
(CMV) reactivation following liver transplantation (OLT), it predisposes patients to late CMV …

Results The incidence of CMV infection and CMV disease was 44% and 3%, respectively.
Acute rejection was significantly associated with CMV infection. Conclusions The incidence …